This webinar, “Precision-Driven Pathways for Long-term Survival in EGFR-Mutant NSCLC,” brings together leading experts to explore how genomic insights can be translated into clinical decision-making and long-term treatment strategies.
The program will cover the evolving role of molecular profiling in guiding personalized therapy, followed by a strategic discussion on optimizing first-line choices and sequential treatment planning to improve long-term outcomes.
Through expert presentations and a panel discussion, this session aims to provide practical perspectives on navigating the increasing complexity of EGFR-mutant NSCLC, with a focus on integrating precision medicine into real-world clinical practice.